Our objective was to examine the effects of specific inhibition of mutant PIK3CA in bladder tumor cells to determine whether mutant PIK3CA can be considered a valid therapeutic target in bladder cancer. This evidence concerns the gene PIK3CA and urinary bladder carcinoma.